newsfilter
← Latest News
GlobeNewswire·

Talaris Therapeutics Announces Addition to the Nasdaq Biotechnology Index

BOSTON and LOUISVILLE, Ky., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc., (NASDAQ:TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation